Latest Research & Analysis

1-Sep-2021 - Bank of America Corporation – BAC:  SEC Investigation Updates 01-Sep-2021:  Bank of America Corp – BAC:  $41.75 Mkt Cap $351.3 B  Removed from Watch List.  We received 9 pages of records from multiple and undisclosed SEC investigations of BAC.  The...

1-Sep-2021 - Hertz Global Holdings Inc. – HTZGQ:   SEC Investigation Updates 01-Sep-2021:  Hertz Global Holdings Inc. – HTZZ:  $16.80 Mkt Cap  7.9 B  Removed from Watch List.  We received 348 pages of records from an undisclosed SEC investigation into Hertz’s Jun-...

1-Sep-2021 - Natera Inc. – NTRA:  SEC Investigation Updates 01-Sep-2021 - Natera Inc. – NTRA: $118.43 Mkt Cap. $11.1 B  Removed from Watch List.  We’ve already written extensively on problems we found at Natera.  Now we received 10 more pages of records, dated Sep-2019 to Jan-...

1-Sep-2021 - Salesforce.com, Inc. – CRM:  SEC Investigation Updates 01-Sep-2021 - Salesforce.com Inc. – CRM   $265.27  Mkt Cap $245.6 Removed from Watch List.  We received one page of records, dated 21-May-2021, from an undisclosed SEC investigation of CRM. It only shows...

31-Aug-2021 - Company’s appearing in today’s research update -- Allogene Therapeutics, Inc. – ALLO  Brixmor Property Group, Inc. – BRX  Collegium Pharmaceutical, Inc. – COLL Gentex Corp. – GNTX  Novavax, Inc. – NVAX  Owens & Minor, Inc. – OMI SunPower...

31-Aug-2021 - Allogene Therapeutics, Inc. – ALLO:  SEC Investigation Update Probes Reporter® research provides data, commentary, and analysis on public company interactions with investors and with the SEC.   Our work is heavily reliant on company disclosures and our expertise in...

31-Aug-2021 - Brixmor Property Group, Inc. – BRX:    SEC Investigation Update Probes Reporter® research provides data, commentary, and analysis on public company interactions with investors and with the SEC.   Our work is heavily reliant on company disclosures and our...

31-Aug-2021 - Collegium Pharmaceutical, Inc. – COLL:  SEC Investigation Update Probes Reporter® research provides data, commentary, and analysis on public company interactions with investors and with the SEC.   Our work is heavily reliant on company disclosures and our expertise in...

Pages